As part of an ongoing series of answers to common questions received by the Basser Center, Executive Director Susan Domchek, MD, discusses PARP inhibitors and ways in which they might be combined with other cancer treatments.

Basser Center genetic counselor Jessica M. Long, MS, LCGC, explains the ins and outs of direct-to-consumer genetic testing for hereditary cancer risk.

Roger Greenberg, MD, PhD, the Basser Center’s Director of Basic Science and the Director of the new Penn Center for Genome Integrity, discusses the new Center and how its research will apply to hereditary cancer and more.

Dana Donofree, designer and founder of AnaOno Intimages, shares her own experience with cancer and discusses how to navigate sexual health and intimacy after surgery.

Jessica M. Long, MS, LCGC, a genetic counselor at the Basser Center, writes about the importance of genetic counseling, potential obstacles to meeting a counselor in person, and remote options.

Jamila Kinsey, a BRCA mutation carrier and patient advocate talks about the importance of raising awareness of breast cancer in the Black community and why this is so vital.

Mackenzie Alleman, a BRCA mutation carrier and patient advocates, shares how she found support and community online and offers suggestions to those looking for help.

Maria Malloy, BSN, RN, OCN, CBCN, a nurse navigator in Penn Medicine’s Breast Cancer program, discusses what to expect from a breast cancer diagnosis.

The Basser Center understands that for BRCA1 and BRCA2 mutation carriers and others at high risk of cancer, COVID-19 may have disrupted screening schedules and surgical plans. While each situation is unique, we offer the following general advice.

Basser Center genetic counselor Jacquelyn Powers, MS, LCGC, discusses genetic counseling via telehealth and what patients can expect from a typical appointment.

Basser Center genetic counselor Jacquelyn Powers, MS, LCGC, writes about her experience seeing patients via telehealth and considerations for the future.

Basser Young Leadership Council member Callum Beale writes about his sister's ongoing battle with BRCA-related cancer and how he is inspired by her bravery.

Melanoma is a rare form of skin cancer that only makes up 1% of overall skin cancers. However, it is a particularly aggressive form, which it is why it’s important to recognize symptoms and know your personal risk for melanoma.

View Basser Center and Penn Medicine resources on the COVID-19 pandemic, particularly geared towards cancer patients and BRCA mutation carriers.

Improving early detection and treatment of ovarian cancer is an important area of focus for the Basser Center for BRCA. Read about the latest research and ongoing studies focusing on screening, preventative surgery, and treatment options for ovarian cancer.

For this year’s National Hispanic Heritage Month (September 15-October 15), we've compiled some helpful hereditary cancer resources for healthcare providers serving Latino patients and families.

For National Previvor Day, Basser Center genetic counselor Becca Mueller, MS, LCGC, writes about the origins of the term and what it means to BRCA mutation carriers.

Patient advocate Erika Stallings writes about her own experiences living with a BRCA mutation and why she has partnered with the Basser Center to begin Black & BRCA, an initiative to raise awareness of hereditary cancer and to bring resources and support to the Black community.